By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Regenicin, Inc. 

New York  New York    U.S.A.
Phone: n/a Fax: n/a



Company News
Regenicin, Inc. Announces Scheduled Pre-IND Meeting With FDA For Its New Autologous Cultured Skin Substitute, NovaDerm 10/12/2016 9:53:46 AM
Regenicin, Inc. Conducts An Evaluation Of Its Proprietary Collagen-Based Scaffold For Use In New Autologous Cultured Skin Substitute 10/5/2016 9:33:36 AM
FDA Grants Orphan-Drug Designation For Regenicin, Inc.'s NovaDerm Cultured Skin Substitute 8/30/2016 8:56:57 AM
Regenicin, Inc. Reports 2015 Operating Results, Outlines Milestones For Q1 2016 2/10/2016 6:35:12 AM
Regenicin, Inc. Enters Into Asset Purchase Agreement With Amarantus Bioscience Holdings, Inc. 11/19/2014 11:38:05 AM
Clarification of Prior Press Release on FDA Issuance of Orphan Status for PermaDerm® -Regenicin, Inc. 6/14/2012 10:18:35 AM
Regenicin, Inc. Release: FDA Issues Orphan Status Approval for PermaDerm® 6/13/2012 10:14:31 AM
Regenicin, Inc. Clears Past Due Payment to Lonza Walkersville, Inc. 6/21/2011 7:45:05 AM
Regenicin, Inc. Announces Repayment of Loans From Financial Backers 6/17/2011 9:11:55 AM
Update: Regenicin, Inc. (RGIN.OB) Announces Dismissal of Lawsuit 6/10/2011 8:45:34 AM